ASPIRE 2023 Conference Review

In this edition:

Utilisation of SOF
Male contributions of unexplained infertility
Fertility preservation in transgender and nonbinary individuals
Improving the thin endometrium
Marketing and advertising of treatment modalities
Utilisation of hysteroscopy guided ET
Low-cost IVF induction
Comparing hCG-OPU intervals of 36 and 37 hours
Safety and efficacy of intrauterine hCG
Clinical and live birth rates in 40–46-year-old women
 

Please login below to download this issue (PDF)

Subscribe